kneat.com (TSE:KSI) Sets New 1-Year High – What’s Next?

Shares of kneat.com, inc. (TSE:KSI) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$6.65 and last traded at C$6.65, with a volume of 40992 shares trading hands. The stock had previously closed at C$6.35.

Analyst Ratings Changes

A number of brokerages have weighed in on KSI. Cibc World Mkts raised kneat.com to a “strong-buy” rating in a research note on Tuesday, October 29th. CIBC set a C$6.00 price objective on shares of kneat.com and gave the company an “outperform” rating in a research note on Tuesday, October 29th.

kneat.com Price Performance

The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14. The company has a market cap of C$566.74 million, a price-to-earnings ratio of -41.19, a P/E/G ratio of 597.67 and a beta of 1.08. The business has a 50-day moving average price of C$5.92 and a 200 day moving average price of C$5.13.

kneat.com (TSE:KSI) last released its earnings results on Wednesday, November 6th. The company reported C$0.01 earnings per share for the quarter, beating the consensus estimate of C($0.05) by C$0.06. kneat.com had a negative net margin of 31.19% and a negative return on equity of 51.13%. During the same period in the previous year, the firm earned ($0.05) earnings per share. As a group, research analysts expect that kneat.com, inc. will post -0.12 earnings per share for the current fiscal year.

About kneat.com

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.